Impact of insulin or incretin hormones in reversing diabetic neuropathy in type 1 and type 2 diabetes mellitus
dc.contributor.advisor | Zochodne, Douglas | |
dc.contributor.author | Kan, Michelle | |
dc.date.accessioned | 2017-12-18T22:20:19Z | |
dc.date.available | 2017-12-18T22:20:19Z | |
dc.date.issued | 2011 | |
dc.description | Bibliography: p. 125-138 | en |
dc.description | A few pages are in colour. | en |
dc.description.abstract | Diabetes mellitus is a metabolic disorder where long-term complications including neuropathy, or nerve damage may arise. Peripheral neuropathy affects approximately 50% of total diabetic patients. Diabetic peripheral neuropathy (DPN) is a length-dependent sensorimotor nerve disorder that can lead to pain, loss of feeling and motor ability. In this work we sought to determine whether insulin or exendin-4 will serve as neurotrophic and neuroprotective factors in both type 1 and type 2 diabetes and reverse DPN pathology. Our results showed that insulin or exendin-4 treatment improved some features of neuropathy in type 1 but not type 2 diabetes. Furthermore, a full reversal of DPN was not observed showing that current clinical dosing of insulin or exendin-4 therapy does not benefit neuropathy. | en |
dc.format.extent | xiii, 138 leaves : ill. ; 30 cm. | en |
dc.identifier.citation | Kan, M. (2011). Impact of insulin or incretin hormones in reversing diabetic neuropathy in type 1 and type 2 diabetes mellitus (Master's thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca. doi:10.11575/PRISM/4182 | en_US |
dc.identifier.doi | http://dx.doi.org/10.11575/PRISM/4182 | |
dc.identifier.uri | http://hdl.handle.net/1880/105183 | |
dc.language.iso | eng | |
dc.publisher.institution | University of Calgary | en |
dc.publisher.place | Calgary | en |
dc.rights | University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission. | |
dc.title | Impact of insulin or incretin hormones in reversing diabetic neuropathy in type 1 and type 2 diabetes mellitus | |
dc.type | master thesis | |
thesis.degree.discipline | Neuroscience | |
thesis.degree.grantor | University of Calgary | |
thesis.degree.name | Master of Science (MSc) | |
ucalgary.item.requestcopy | true | |
ucalgary.thesis.accession | Theses Collection 58.002:Box 2019 627942869 | |
ucalgary.thesis.notes | UARC | en |
ucalgary.thesis.uarcrelease | y | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- thesis_Kan_2011.pdf
- Size:
- 60.84 MB
- Format:
- Adobe Portable Document Format
- Description: